PF-04518600, PF-8600

Collapse Summary General Information
Company Pfizer Inc.
Description mAb against tumor necrosis factor (TNF) receptor superfamily member 4 (OX40; TNFRSF4; CD134)
Molecular Target Tumor necrosis factor (TNF) receptor superfamily member 4 (OX40) (TNFRSF4) (CD134)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/26/2017

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today